Trial Profile
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Bone resorption; Fracture
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms VITAL
- 08 Nov 2022 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 08 Nov 2022 Status changed from completed to active, no longer recruiting.
- 28 Jan 2021 Results assessing changes in total weight or fat and lean tissue measurements assessed by DXA from this ancillary study (NCT01747447) of VITAL parent study (NCT01704859) published in the Journal of Clinical Endocrinology and Metabolism